🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Fire-fighters are at increased risk of death from heart attacks when compar...
Status
Completed
Location
Royal Infirmary of Edinburgh Clinical Research Facility
Start Date
2012-04
Trial ID
NCT01812317
Treatments Being Tested
Will Abatacept reduce priming of the hair follicle specific T cells and the...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01314495
Treatments Being Tested
Protocol PICO-RWE-001: The goal of this observational study is to evaluate ...
Status
Not Yet Recruiting
Location
PICO IV Central Data Coordinating Center
Start Date
2026-05-21
Trial ID
NCT07609069
This study is a randomized, placebo-controlled, phase 2a trial to study the...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Neurological Clinical Research Institute
Start Date
2019-08-07
Trial ID
NCT04055623
Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascendi...
Status
Completed
Location
Banner University Medical Center
Start Date
2022-04-26
Trial ID
NCT05184764
The purpose of this study is to elucidate whether SentoClone® gives improve...
Status
Unknown
Location
Lunds Universitetssjukhus
Start Date
2009-10
Trial ID
NCT00991250
Treatments Being Tested
This study is a multicenter, randomized, double-blind, placebo parallel con...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital, Sun Yat-sen University
Start Date
2024-01-01
Trial ID
NCT06085378
Treatments Being Tested
This is a prospective, randomized, double-blind, placebo-controlled, parall...
Status
Terminated
Location
Memorial Hospital Central
Start Date
2012-03
Trial ID
NCT01362205
Treatments Being Tested
This study is being conducted to evaluate the pharmacokinetic (PK) and safe...
Status
Completed
Location
ML-ORI-102 Study Site
Start Date
2019-07-16
Trial ID
NCT03873987
Treatments Being Tested